Literature DB >> 21482353

Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses.

Julie M Miwa1, Robert Freedman, Henry A Lester.   

Abstract

Cholinergic neurons and nicotinic acetylcholine receptors (nAChRs) in the brain participate in diverse functions: reward, learning and memory, mood, sensory processing, pain, and neuroprotection. Nicotinic systems also have well-known roles in drug abuse. Here, we review recent insights into nicotinic function, linking exogenous and endogenous manipulations of nAChRs to alterations in synapses, circuits, and behavior. We also discuss how these contemporary advances can motivate attempts to exploit nicotinic systems therapeutically in Parkinson's disease, cognitive decline, epilepsy, and schizophrenia.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482353      PMCID: PMC4418790          DOI: 10.1016/j.neuron.2011.03.014

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  151 in total

1.  lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS.

Authors:  J M Miwa; I Ibanez-Tallon; G W Crabtree; R Sánchez; A Sali; L W Role; N Heintz
Journal:  Neuron       Date:  1999-05       Impact factor: 17.173

2.  Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.

Authors:  Sherry Leonard; Judith Gault; Jan Hopkins; Judith Logel; Ruby Vianzon; Margaret Short; Carla Drebing; Ralph Berger; Diana Venn; Pinkhas Sirota; Gary Zerbe; Ann Olincy; Randal G Ross; Lawrence E Adler; Robert Freedman
Journal:  Arch Gen Psychiatry       Date:  2002-12

3.  RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells.

Authors:  Stuart J Lansdell; Veronica J Gee; Patricia C Harkness; Anne I Doward; Elizabeth R Baker; Alasdair J Gibb; Neil S Millar
Journal:  Mol Pharmacol       Date:  2005-08-24       Impact factor: 4.436

4.  Short- and long-lasting consequences of in vivo nicotine treatment on hippocampal excitability.

Authors:  Rachel E Penton; Michael W Quick; Robin A J Lester
Journal:  J Neurosci       Date:  2011-02-16       Impact factor: 6.167

5.  Temporal and regional regulation of gene expression by calcium-stimulated adenylyl cyclase activity during fear memory.

Authors:  Lindsay Wieczorek; James W Maas; Lisa M Muglia; Sherri K Vogt; Louis J Muglia
Journal:  PLoS One       Date:  2010-10-14       Impact factor: 3.240

Review 6.  Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.

Authors:  Henry A Lester; Cheng Xiao; Rahul Srinivasan; Cagdas D Son; Julie Miwa; Rigo Pantoja; Matthew R Banghart; Dennis A Dougherty; Alison M Goate; Jen C Wang
Journal:  AAPS J       Date:  2009-03-12       Impact factor: 4.009

7.  SLURP-1 and -2 in normal, immortalized and malignant oral keratinocytes.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Sergei A Grando
Journal:  Life Sci       Date:  2007-01-13       Impact factor: 5.037

8.  Dopamine enables in vivo synaptic plasticity associated with the addictive drug nicotine.

Authors:  Jianrong Tang; John A Dani
Journal:  Neuron       Date:  2009-09-10       Impact factor: 17.173

Review 9.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

10.  A role for LYNX2 in anxiety-related behavior.

Authors:  Ayse B Tekinay; Yi Nong; Julie M Miwa; Ivo Lieberam; Ines Ibanez-Tallon; Paul Greengard; Nathaniel Heintz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

View more
  106 in total

1.  Live-cell imaging of single receptor composition using zero-mode waveguide nanostructures.

Authors:  Christopher I Richards; Khai Luong; Rahul Srinivasan; Stephen W Turner; Dennis A Dougherty; Jonas Korlach; Henry A Lester
Journal:  Nano Lett       Date:  2012-06-08       Impact factor: 11.189

Review 2.  Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Authors:  Laura L Hurley; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-09-20       Impact factor: 3.911

Review 3.  Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects.

Authors:  Henry A Lester; Julie M Miwa; Rahul Srinivasan
Journal:  Biol Psychiatry       Date:  2012-07-06       Impact factor: 13.382

4.  The nicotine metabolite, cotinine, alters the assembly and trafficking of a subset of nicotinic acetylcholine receptors.

Authors:  Ashley M Fox; Faruk H Moonschi; Christopher I Richards
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

5.  PMCA2 via PSD-95 controls calcium signaling by α7-containing nicotinic acetylcholine receptors on aspiny interneurons.

Authors:  David Gómez-Varela; Manuela Schmidt; Jeff Schoellerman; Eric C Peters; Darwin K Berg
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

6.  N-glycosylation in regulation of the nervous system.

Authors:  Hilary Scott; Vladislav M Panin
Journal:  Adv Neurobiol       Date:  2014

Review 7.  Inside-out neuropharmacology of nicotinic drugs.

Authors:  Brandon J Henderson; Henry A Lester
Journal:  Neuropharmacology       Date:  2015-02-04       Impact factor: 5.250

8.  Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.

Authors:  Jason R Tregellas; Jason Smucny; Josette G Harris; Ann Olincy; Keeran Maharajh; Eugene Kronberg; Lindsay C Eichman; Emma Lyons; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

9.  A cholinergic basal forebrain feeding circuit modulates appetite suppression.

Authors:  Alexander M Herman; Joshua Ortiz-Guzman; Mikhail Kochukov; Isabella Herman; Kathleen B Quast; Jay M Patel; Burak Tepe; Jeffrey C Carlson; Kevin Ung; Jennifer Selever; Qingchun Tong; Benjamin R Arenkiel
Journal:  Nature       Date:  2016-10-03       Impact factor: 49.962

10.  Water-soluble LYNX1 residues important for interaction with muscle-type and/or neuronal nicotinic receptors.

Authors:  Ekaterina N Lyukmanova; Mikhail A Shulepko; Svetlana L Buldakova; Igor E Kasheverov; Zakhar O Shenkarev; Roman V Reshetnikov; Sergey Y Filkin; Denis S Kudryavtsev; Lucy O Ojomoko; Elena V Kryukova; Dmitry A Dolgikh; Mikhail P Kirpichnikov; Piotr D Bregestovski; Victor I Tsetlin
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.